Section: 17-10302

COVERED SUBSTANCES

Most recent version of the final adopted rule codified in the D.C. Municipal Regulations (DCMR)


Effective Date : 6/7/2019 12:00:00 AM

Authority : Sections 3 and 11 of the Prescription Drug Monitoring Program Act of 2013, effective February 22, 2014 (D.C. Law 20-66; D.C. Official Code §§ 48-853.02 and 48-853.10 (2014 Repl. & 2015 Supp.)).

Source : Final Rulemaking published at 62 DCR 15828 (December 11, 2015); as amended by Final Rulemaking published at 66 DCR 6830 (June 7, 2019).

Editor's Note :

Rulemaking notices were published in the D.C. Register(DCR) and Adopted Rules were codified into the D.C. Municipal Regulations (DCMR)

  Notice ID Register Category Heading Notice/
Adopted Section 		Register Issue/
Effective Date
R0038198 Adopted Rule COVERED SUBSTANCES View Text Effective:
6/7/2019
N0083235 Final Rulemaking Health, Department of (DC Health) - Notice of Final Rulemaking - Adding Gabapentin to the list of covered substances as a drug of concern for PDMP reporting. View Text 6/7/2019
Vol 66/23
N0078625 Proposed Rulemaking Health, Department of (DC Health) - Notice of Proposed Rulemaking - Adding Gabapentin to PDMP Reporting Requirements as a Covered Substance View Text 2/1/2019
Vol 66/5
R0017922 Adopted Rule COVERED SUBSTANCES View Text Effective:
12/11/2015
N0056244 Final Rulemaking Health, Department of- Final Rulemaking for the Prescription Drug Monitoring Program View Text 12/11/2015
Vol 62/51
N0055027 Proposed Rulemaking Health, Department of - Notice of Proposed Rulemaking - To Implement the District of Columbia Prescription Drug Monitoring Program View Text 9/11/2015
Vol 62/38
Other rules using the same rule number